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BCAP: The Tyrosine Kinase Substrate
that Connects B Cell Receptor to
Phosphoinositide 3-Kinase Activation
eration of downstream second messengers have been
an area of intense investigation.
The efficient and coordinated generation of a number
of second messengers, including IP3 (inositol[1,4,5]tris-
phosphate) and PI(3,4,5)P3 (phosphatidylinositol[3,4,5]
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Kansai Medical University trisphosphate), is required for normal B cell function.
Phosphoinositide 3-kinase (PI3K) is responsible for theMoriguchi 570-8506
†Center Laboratories for Key Technology production of PI(3,4,5)P3 and participates in the regula-
tion of cell proliferation, survival, metabolism, cytoskele-Kirin Brewery Company
Yokohama 236-0004 tal reorganization, and membrane trafficking (Leevers
et al., 1999; Rameh and Cantley, 1999). Heterodimer-‡Laboratories of Humoral Information
National Institute for Physiological Sciences type (class Ia) PI3Ks consist of a catalytic subunit (p110)
and a regulatory subunit encoded by at least three dis-Okazaki 444-8585
Japan tinct genes (p85a, p85b, and p55g). p85a is the most
abundantly expressed regulatory isoform of PI3K, and
the importance of this subunit for B cell development
and proliferation has been recently underscored by gene
Summary targeting experiments in mice. In fact, the proliferative
response of B cells to BCR stimulation was diminished
Tyrosine phosphorylation of adaptor proteins permits in the absence of the p85a subunit (Fruman et al., 1999;
the B cell antigen receptor (BCR)-associated protein Suzuki et al., 1999).
tyrosine kinases to regulate downstream effector mol- Despite the key role of the p85 subunit in BCR signal-
ecules. Here, we report the identification of a novel ing, the mechanism by which the BCR-associated PTKs
B cell adaptor for phosphoinositide 3-kinase (PI3K), regulate the PI3K pathway still remains unclear. This
termed BCAP. Tyrosine phosphorylation of BCAP is mechanism is likely to involve the two SH2 domains of
mediated by Syk and Btk, thereby providing binding the p85 subunit. Both SH2 domains bind with high affin-
site(s) for the p85 subunit of PI3K. Disruption of the ity to phosphotyrosines in the YxxM motif, and this SH2-
BCAP gene in the DT40 B cell line inhibits BCR-medi- dependent binding to docking proteins is thought to be
ated phosphatidylinositol 3,4,5-trisphosphate genera- important for recruitment of PI3K to the plasma mem-
tion, leading to impaired Akt response. Moreover, brane and for increasing the specific activity of the en-
recruitment of PI3K to glycolipid-enriched microdo- zyme (Shoelson et al., 1993; Fruman et al., 1998). Such
mains (GEMs) is significantly attenuated in the ab- docking partners include CD19, a B cell–specific mem-
sence of BCAP. Hence, these data suggest that BCAP brane protein containing two YxxM motifs in its cyto-
bridges BCR-associated kinases to the PI3K pathway plasmic region. Indeed, when stimulated by BCR, CD19
by regulating PI3K localization. is tyrosine phosphorylated, thereby providing the bind-
ing site(s) to the p85 subunit (Tuveson et al., 1993; Buhl
and Cambier, 1999). However, given that B cell develop-Introduction
mental and functional defects in p85a2/2 mice are more
severe than those in CD192/2 mice, this CD19-mediatedB cell antigen receptor (BCR) engagement triggers a
activation mechanism seems not to fully account for thecascade of biochemical events that culminate in B cell
activation mode of the PI3K (Engel et al., 1995; Rickertactivation, which entails the proliferation and differentia-
et al., 1995; Fruman et al., 1999; Suzuki et al., 1999).tion of B cells. The BCR utilizes phosphorylation of the
Based upon the hypothesis that additional adaptorIga and Igb immunoreceptor tyrosine-based activation
molecules may participate in linking between BCR-motifs (ITAMs) to activate nonreceptor protein tyrosine
associated PTKs and PI3K, we have purified a novelkinases (PTKs). Sequential activation of three distinct
protein, termed BCAP, by using the p85 SH2 domain.classes of PTKs (the Src-PTKs, Syk, and Btk) is required
Here, we report the molecular and functional character-for regulating downstream signaling pathways. Indeed,
ization of BCAP and demonstrate that BCAP plays andeficiencies in any of these three families of PTKs result
important role in BCR-mediated PI3K activation.in defective or aberrant B cell function and development
(DeFranco, 1997; Reth and Wienands, 1997; Tamir and
ResultsCambier, 1998; Kurosaki, 1999). Thus, the mechanisms
by which these BCR-associated PTKs regulate the gen-
Molecular Identification of BCAP
The strategy used for purifying BCAP was based upon
§ To whom correspondence should be addressed (e-mail: kurosaki@ its ability to associate with SH2 domains of PI3K p85
mxr.mesh.ne.jp). subunits following BCR cross-linking. As each SH2 do-k These authors contributed equally to this work.
main of the p85 subunit has been shown to bind with# Present address: Bayer Chair of Department of Molecular Immu-
high affinity to similar phosphotyrosine-containing se-nology and Allergy, Kyoto University, Faculty of Medicine, Yoshida
Konoe-cho, Sakyo-ku, Kyoto 606-8315, Japan. quences (Songyang et al., 1993), we have employed a
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Figure 1. Cloning of a Novel Protein BCAP
(A) The Ponceau S staining of pp100. The position of pp100, excised for microsequencing, is indicated by the bracket on the right.
(B) The sequences of chicken and mouse BCAP were aligned by the CLUSTAL X program (Thompson et al., 1997). Identical amino acids are
in the filled boxes. The chicken sequence represents clone 2. The arrow indicates the start of the open reading frame of clone 11. Peptide
sequences obtained from microsequencing were as follows (amino acid number): AQRPENL (560–566), TPGQRQLITLQEQV (599–612), IVPYSIE
ALDK (293–303), FLEGGSTDAPDSGE (492–505), ETIVRPVRDLS (576–586), and MGILNVDEAVL (614–624).
(C) Schematic representation of predicted motifs and structures in the chicken BCAP and Drosophila Dof proteins. The ankyrin repeats (BCAP
amino acids 336–404), the coiled coils (636–666), and the proline-rich regions (532–538, 773–779, and 792–798) are indicated by boxed “AR,”
“CC,” and “P,” respectively. Potential tyrosine phosphorylation sites (with amino acid numbers in the brackets) known for SH2 binding motifs
are indicated: YxxM for PI3K, YxNx for Grb2, and YxxV for SHP-2. The coiled-coil prediction was according to the algorithm of A. Lupas
(Lupas, 1996).
two-step affinity purification with the immobilized N-ter- clone encodes an 811 amino acid polypeptide that
shares 65% identity to the predicted chicken BCAP (Fig-minal SH2 domain of p85 and anti-phosphotyrosine
mAb, leading to isolation of pp100 from BCR-activated ure 1B). Comparison of the deduced primary amino acid
sequence of BCAP with the NCBI protein databasechicken DT40 B cells (see Experimental Procedures).
Six internal peptide sequences were obtained from mi- shows weak homology to Drosophila Dof protein (Fig-
ure 1C) (Vincent et al., 1998). Both BCAP and Dof havecrosequencing of pp100 (Figure 1A), and the sequences
TPGQRQLITLQEQV and IVPYSIEALDK were used to an ankyrin repeat-like sequence (residues 336–404 in
chicken BCAP and residues 366–440 in Dof) and a shortgenerate degenerate oligonucleotides. A DT40 cDNA
library was screened by mixtures of these oligonucleo- sequence predicted to form a coiled-coil structure (resi-
dues 633–666 in chicken BCAP and residues 703–741tides, leading to isolation of a 2.7 kb cDNA clone (clone
2). Its open reading frame gives rise to an 800 amino in Dof). Chicken BCAP contains 31 potential tyrosines
that may become phosphorylated. As potential SH2acid polypeptide with a calculated molecular weight of
90,152 Da (Figure 1B). The six peptides derived from binding sites (Songyang et al., 1993, 1994), BCAP pos-
sesses four YxxM motifs (PI3K p85 subunit), one YxNxpp100 were all present in the open reading frame. The
slight increase in the apparent molecular weight esti- motif (Grb2), and one YxxV motif (SHP-2), while Dof has
one YxxM motif, five YxNx motifs, and one YxxV motifmated from SDS-polyacrylamide gels of 100,000 Da
could be due to the acidic nature of the BCAP polypep- (Figure 1C). In addition, BCAP but not Dof contains three
conserved proline-rich regions predicted to bind Src-tide (calculated isoelectric point, 4.85).
The murine counterpart of chicken BCAP was also PTKs, PLC-g, and Grb2 N-terminal SH3 domains (Figure
1C) (Sparks et al., 1996).cloned from a mouse spleen cDNA library. An isolated
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Figure 2. Expression of BCAP
(A) Northern blot analysis of BCAP RNA ex-
pression in mouse tissues and cell lines (up-
per panel). For loading control, the ethidium
bromide staining image of tissue RNAs and
the blot with the b-actin cDNA probe of cell
line RNAs are shown in the lower panels.
(B) Western blot analysis of BCAP protein ex-
pression in DT40 (left panel) and mouse
splenic B cells (right panel). Cell lysates and
immunoprecipitates with anti-chicken BCAP
Ab or anti-mouse BCAP Ab were separated
on 7.5% SDS-PAGE gel and blotted with anti-
BCAP Ab. In the left panel, BCAP immunopre-
cipitates from BCAP-deficient DT40 cells and
from COS cells transfected with chicken
BCAP cDNA clone 2 or clone 11 were also
analyzed. The positions of the multiple BCAP
species BCAP1-4 are indicated.
(C) Schematic representation of the chicken
BCAP gene segment responsible for produc-
ing two alternative transcripts. The exons are
depicted by boxes. The exon encoding the
initiation methionine for clone 2 is located
further upstream of the region shown here.
The middle exon containing the primer “b”
sequence corresponds to the alternative 59
sequence found in clone 11, and the first me-
thionine for clone 11 (methionine 169 in Figure
1B) is encoded in the exon containing the
primer “c.” The joint of the exons encoding
clone 2 forms the codon of aspartic acid (the
residue 144) in the 800 amino acid polypep-
tide shown in Figure 1B. Ethidium bromide
staining image of DNA fragments amplified
from reverse transcripts of DT40 RNA and
from DT40 genomic DNA with the sense
primer “a” (59-GGCAAGAACTCACGTATGAT
GATGAG-39) or “b” (59-GGATCAGGATCCCTT
CAGACTACTG-39) and the antisense primer
“c” (59-GGCAAGTTGACAGGAGTAAACTGA
GG-39).
(D and E) Cellular localization of BCAP. Wild-
type (wt) and BCAP-deficient DT40 cells
(BCAP2) were stained with anti-BCAP Ab
(green) and with propidium iodide for nuclear
staining (red) and were visualized by confocal
microscopy (upper panels in [D]). In lower
panels, COS cells transiently transfected with
BCAP cDNA clone 2 (COS/BCAP) and nontransfected COS cells (COS) were stained with anti-BCAP Ab and propidium iodide. Cytosolic and
membrane fractions of DT40 cells, unstimulated (minus symbol) or stimulated with 4 mg/ml M4 for 2 min (plus symbol), were resolved by SDS-
PAGE and immunoblotted with anti-chicken BCAP Ab or M4 (E).
Distribution of BCAP transcripts was investigated by lecular weight values of 100, 98, 72, and 70 kDa (for
reference, designated BCAP4, BCAP3, BCAP2, andNorthern blot analyses using various mouse tissues and
cell lines (Figure 2A). Transcripts were seen predomi- BCAP1, respectively) in lysates of both DT40 and mouse
splenic B cells (Figure 2B). Ablation of the chicken BCAPnantly in spleen and at low levels in thymus, liver, and
lung. BCAP mRNA was expressed in the B cell lines gene resulted in loss of all four protein species, sug-
gesting that these species could arise from alternative(WEHI279 and L1210), pre-B cell line (18–81), and macro-
phage cell lines (P388D1 and WEHI3) but not in the transcripts of the BCAP gene and/or posttranslational
modifications. To examine these possibilities, we exten-plasma cell lines (J558L and P3U1), T cell lines (EL-4
and BW5147), mast cell line (P815), erythroid cell line sively screened the DT40 cDNA library, leading to isola-
tion of a 2.5 kb cDNA clone (clone 11) containing the(B813), or several nonhematopoietic cell lines (B16, Y1,
NIH3T3, and ES-E14). Based on these data, we conclude alternative 59 sequence. The open reading frame of
clone 11 encodes a 632 amino acid polypeptide with thethat BCAP is expressed predominantly in B cells and
macrophages. truncated N-terminal sequence (a calculated molecular
weight of 70,904 Da) (see legend of Figure 1B). Expres-Protein expression of BCAP in B cells was analyzed
with polyclonal Abs raised against chicken BCAP (resi- sion of cDNA clone 11 in COS cells gave rise to proteins
that comigrated with BCAP1/BCAP2, while proteins co-dues 410–540) and mouse BCAP (residues 603–797).
Western blot analyses detected four proteins with mo- migrated with BCAP3/BCAP4 emerged upon transfec-
Immunity
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Figure 3. BCR-Induced Tyrosine Phosphorylation of BCAP
(A) Tyrosine phosphorylation of BCAP and its association with p85 in DT40 cells (left panel) and mouse splenic B cells (right panel). At the
indicated time points after BCR stimulation (4 mg/ml M4 for DT40 cells and 15 mg/ml anti-mouse IgM (Fab)2 fragment for mouse splenic B
cells), immunoprecipitates with anti-chicken BCAP or anti-mouse BCAP Ab (5 3 106 DT40 cells/lane and 1 3 107 mouse splenic B cells/lane)
were separated on 7.5% SDS-PAGE gel and analyzed by Western blotting with 4G10, anti-BCAP Ab, or anti-p85 Ab. As a negative control
experiment, we also analyzed BCAP-deficient DT40 cells. The positions of the multiple BCAP species BCAP1-6 are indicated.
(B) Tyrosine phosphorylation of CD19 and its association with p85 in mouse splenic B cells.
(C) BCAP tyrosine phosphorylation in DT40 cells deficient in Lyn, Syk, or Btk.
tion of clone 2 (Figure 2B). Furthermore, the existence of cies undergo receptor-dependent tyrosine phosphory-
lation that peaks at 1 min and returns to nearly basalthe alternative exon responsible for the 59 untranslated
region of clone 11 was confirmed by genomic PCR anal- levels by 30 min (Figure 3A; data not shown). The tyro-
sine phosphorylation extent of BCAP3/BCAP4 was z5-ysis (Figure 2C). Hence, the most likely possibility is that
BCAP3/BCAP4 and BCAP1/BCAP2 represent the two fold higher than that of BCAP1/BCAP2, determined by
the ratio of the anti-phosphotyrosine signal to the anti-distinct transcripts generated by alternative initiation or
splicing. In contrast to immunoprecipitates, NP-40 cell BCAP signal. Moreover, in addition to these four spe-
cies, two more slowly migrated species (shown bylysates exhibited predominant detection of chicken
BCAP2/BCAP4 compared with chicken BCAP1/BCAP3 BCAP5 and BCAP6) were detected in DT40 B cells after
BCR cross-linking, and their phosphorylation peaks(Figure 2B), suggesting that anti-chicken BCAP Ab used
in this study might have higher affinity for BCAP1/BCAP3 were relatively delayed (10 min) compared with that of
BCAP3/BCAP4. These observations suggest the hetero-than BCAP2/BCAP4 in their native conformations.
The cellular localization of BCAP was analyzed by geneity of the tyrosine phosphorylation status on BCAP
after BCR cross-linking. The heterogeneity of BCAP ty-immunofluorescence in DT40 B cells. BCAP was distrib-
uted in the cytoplasm and plasma membrane but not in rosine phosphorylation status after BCR stimulation was
also detected in mouse splenic B cells, although thethe nuclear region of DT40 cells (Figure 2D). No staining
was detected in BCAP-deficient DT40 cells. The cyto- extents of tyrosine phosphorylation of mouse BCAP1
and BCAP2 were relatively high compared with chickenplasmic and plasma membrane localization was also
seen for ectopically expressed BCAP in COS cells (Fig- ones. In the case of mouse splenic B cells, tyrosine
phosphorylation of BCAP declined more rapidly than inure 2D). Consistent with the microscopic analysis, sub-
cellular fractionation of DT40 cells revealed the exis- DT40 cells (Figure 3A).
To identify the PTKs responsible for BCAP tyrosinetence of BCAP in both cytosolic and membrane fractions
(Figure 2E). phosphorylation upon BCR cross-linking, we analyzed
BCAP phosphorylation in a cohort of chicken DT40 cell
lines lacking Lyn, Syk, or Btk (Figure 3C) (Takata et al.,Tyrosine Phosphorylation of BCAP Is Mediated
by Syk and Btk 1994; Takata and Kurosaki, 1996). In Lyn-deficient cells,
the tyrosine phosphorylation of BCAP5/BCAP6 wasImmunoprecipitation of BCAP from resting and BCR-
activated DT40 B cells demonstrated that all four spe- markedly increased, although the phosphorylation ex-
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tents of BCAP3 and BCAP4 were attenuated. In contrast,
only marginal phosphorylation of BCAP3/BCAP4 was
observed in Syk-deficient DT40 cells. In Btk-deficient
DT40 cells, BCAP was tyrosine phosphorylated to a simi-
lar extent after 1 min of BCR stimulation as wild-type
cells, while this phosphorylation declined by 10 min fol-
lowing the onset of BCR stimulation (Figure 3C). Taken
together, these data suggest that Syk and Btk contribute
to initiating and sustaining BCAP phosphorylation, re-
spectively, in the BCR signaling context. Because Btk
is activated to some extent even in Syk-deficient DT40
cells (Kurosaki and Kurosaki, 1997), the residual phos-
phorylation of BCAP observed in Syk-deficient cells may
reflect the compensatory action of Btk in initiating BCAP
phosphorylation. Our results also demonstrate that, in
contrast to a positive role of Syk and Btk, Lyn plays a
negative role in BCR-mediated tyrosine phosphorylation
of BCAP.
Association of BCAP with PI3K p85 in B Cells
Since BCAP was purified as a binding partner to the
N-terminal SH2 domain of the PI3K p85 subunit in vitro,
we examined whether the interaction between BCAP
and p85 occurs in vivo in B cells. Immunoprecipitates
of BCAP were examined for association with PI3K p85
from resting and BCR-activated B cells. As shown in
Figure 3A, p85 inducibly associated with BCAP upon
BCR stimulation in both chicken DT40 and mouse
splenic B cells, and p85 could not be detected in im-
munoprecipitates from BCAP-deficient DT40 cells. The
extent of p85 association with BCAP was well correlated
with BCAP tyrosine phosphorylation status (Figure 3A).
Consistent with the previous reports (Tuveson et al.,
1993; Buhl and Cambier, 1999), p85 also associated
with CD19 after BCR stimulation in splenic B cells (Fig-
ure 3B).
Figure 4. Disruption of the BCAP Gene in Chicken DT40 B CellsBCAP Is Involved in BCR-Induced PI3K Activation
Loss of BCAP expression by targeted disruption of BCAP gene wasTo address the function of BCAP, we established BCAP-
already shown in Figures 2 and 3A.deficient DT40 lines by the gene-targeting method (see
(A) Cell surface expression of BCR on wild-type and BCAP-deficientExperimental Procedures). Lack of BCAP expression
DT40 cells. Analyses of transformants expressing wild-type chicken
was confirmed by Western blot analyses (Figure 3A). BCAP (wt/BCAP2) or mutant chicken BCAP(Y4F) (Y4F/BCAP2) in
The level of cell surface expression of BCR on BCAP- BCAP-deficient cells were also shown here (see also Figure 6).
(B) BCR-induced tyrosine phosphorylation in wild-type and BCAP-deficient DT40 clones was essentially the same as that
deficient DT40 cells. At the indicated time points after stimulationof parental DT40 cells (Figure 4A). Little change of the
with M4 (4 mg/ml), whole-cell lysates prepared from 2 3 106 cellsBCR-induced overall tyrosine phosphorylation was de-
were loaded onto SDS-PAGE (8% gel) and analyzed by Westerntected between wild-type and BCAP-deficient DT40
blotting with 4G10.
cells (Figure 4B), suggesting that the BCR-associated
PTKs such as Lyn and Syk are activated normally in the
absence of BCAP. treatment, and only marginal JNK activation was de-
tected in BCAP-deficient DT40 cells (Figure 5C). AsTo examine the effect of BCAP on PI3K signaling, we
measured the in vivo accumulation of PI(3,4,5)P3 in wild- predicted from the decrease of Akt activation in BCAP-
deficient DT40 B cells, BCR-induced apoptosis was sig-type and BCAP-deficient DT40 cells. BCR stimulation
increased radiolabeled PI(3,4,5)P3 content in DT40 cells, nificantly enhanced in the mutant cells (Figure 5D)
because Akt is well known to prevent apoptosis (Dattawhich was abolished by prior treatment with 100 nM
wortmannin. As shown in Figure 5A, BCR-mediated et al., 1999). In addition, as PI(3,4,5)P3 accumulation was
reported to be involved in PLC-g activation through TecPI(3,4,5)P3 accumulation was attenuated by 50% in
BCAP-deficient cells, leading to the 2-fold decrease of kinases including Btk (Scharenberg and Kinet, 1998),
we measured BCR-induced IP3 generation and foundAkt activation (Figure 5B). Since JNK activation is also
shown to be PI3K dependent in many systems (Klippel that it was also significantly diminished in BCAP-defi-
cient cells (Figure 5E). Collectively, these results demon-et al., 1996; Timokhina et al., 1998), we also examined
the effect of BCAP on JNK activation. Indeed, the BCR- strate a critical role for BCAP in activating the PI3K
pathway. However, the residual PI(3,4,5)P3 accumulationinduced JNK activation was abolished by wortmannin
Immunity
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Figure 5. Impairment of BCR-Induced PI3K Signaling in the Absence of BCAP
(A) PI(3,4,5)P3 quantitation in wild-type and BCAP-deficient DT40 cells. Cells loaded with [32P]orthophosphate were incubated with or without
100 nM wortmannin for 10 min and stimulated with M4 (4 mg/ml). The spot of PI(3,4,5)P3 marker is indicated by an arrowhead. A typical
example of these results is shown in the upper panel. In the lower panel, fold increases of PI(3,4,5)P3 level normalized to total phospholipids
after BCR stimulation are shown. The results are shown by average and SEM of three independent experiments (see Experimental Procedures).
The actual percentages of PI(3,4,5)P3 radioactivity in total phospholipids at time zero were 0.15% 6 0.03%, 0.13% 6 0.04%, and 0.07% 6
0.01% in wild-type DT40 cells, BCAP-deficient DT40 cells, and wortmannin-treated wild-type cells, respectively.
(B and C) BCR-induced activation of Akt (B) and JNK (C) in wild-type and BCAP-deficient DT40 cells. After 10 min incubation with or without
100 nM wortmannin, cells were stimulated with 4 mg/ml M4 for the indicated time. Akt and JNK were immunoprecipitated and assayed for in
vitro kinase activity using histone H2B and GST-cJun, respectively, as a substrate. The reactions were separated by SDS-PAGE and autoradio-
gramed (upper panels). The protein levels of Akt and JNK in immunoprecipitates were analyzed by Western blot analysis (lower panels).
(D) Induction of apoptosis in wild-type and BCAP-deficient DT40 cells. Cells were cultured with (plus symbol) or without (minus symbol) M4
(10 mg/ml) for 24 hr, stained with 50 mg/ml propidium iodide, and subjected to flow cytometric analysis. The percentage of endonucleolytically
cleaved DNA is indicated.
(E) BCR-induced IP3 generation in wild-type and BCAP-deficient DT40 cells (2 3 106 cells/sample).
in BCAP-deficient DT40 B cells suggests the existence (Figures 6A and 6B). Likewise, BCR-induced JNK acti-
vation was restored by wild-type BCAP but not byof BCAP-independent PI3K activation mechanism(s) in
B cells. BCAP(Y4F) (Figure 6C). Therefore, these data further
support our conclusion that, after being phosphorylated,
BCAP provides the docking site(s) for the p85 SH2 do-Phosphorylation of YxxM Motifs in BCAP Is Critical
mains, thereby participating in PI3K activation. IP3 pro-for PI3K Activation
duction was restored completely by wild-type BCAPTo address the requirement for the YxxM motifs of BCAP
and partially by BCAP(Y4F) (data not shown), suggesting(clone 2) in PI3K activation, we generated a mutant
that BCAP contributes to PLC-g activation in both YxxMchicken BCAP in which the four potential YxxM motifs
motif-dependent and -independent manners.were mutated to FxxM sequences. When expressed in
BCAP-deficient DT40 B cells, significant tyrosine phos-
phorylation of BCAP(Y4F) was still observed upon BCR Translocation of p85 to GEMs Is Attenuated
in BCAP-Deficient Cellsengagement, indicating the existence of additional tyro-
sine phosphorylation sites in BCAP (Figure 6A). How- Recruitment of PI3Ks to the membrane is an essential
process for the regulation of the enzymes by growthever, phosphorylation of BCAP5/BCAP6 in BCAP(Y4F)
was decreased as compared with wild-type BCAP. De- factor receptors (Klippel et al., 1996; Gillham et al., 1999).
Furthermore, it has been recently demonstrated that,spite the residual phosphorylation of BCAP(Y4F), this
mutant BCAP failed to associate with the PI3K p85 sub- upon TCR engagement, PI3Ks are redistributed to spe-
cial subdomains of the plasma membrane known asunit as well as to restore the defective Akt activation
B Cell Adaptor for PI3K Activation
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BCAP, like LAT in T cells, is constitutively localized in
GEMs and therefore functions as a scaffold protein in
BCR signaling (Zhang et al., 1998). However, in the
case of BCAP, the majority of BCAP was localized in
non-GEMs before stimulation, though a small fraction
of BCAP was reproducibly observed in GEMs. The
amounts of BCAP proteins in GEMs were not signifi-
cantly changed upon BCR engagement, while a presum-
ably phosphorylated form of BCAP emerged after BCR
stimulation (Figure 7).
Discussion
Despite the importance of the PI3K p85a subunit for B
cell development and BCR signaling, the exact nature
of the connection between BCR-activated PTKs and
PI3K is still unclear. Here, we report the identification
and characterization of a novel PTK substrate, BCAP,
which couples BCR to PI3K activation. Using DT40 cell
lines deficient in Lyn, Syk, and Btk, we found that both
Syk and Btk contribute to BCAP tyrosine phosphoryla-
tion. Thus, the previous evidence that BCR-mediated
PI3K activation is attenuated in Syk-deficient B cells
could be explained, at least partly, by the requirement
for Syk in BCAP phosphorylation (Beitz et al., 1999). In
contrast to a severe overall attenuation of BCAP phos-
phorylation in Syk-deficient B cells, Btk-deficient cells
exhibited the defect particularly in the sustained phase
of BCAP phosphorylation (Figure 3C). The straightfor-
ward interpretation of these data is that Syk and Btk
participate in initiating and sustaining BCAP phosphory-Figure 6. Requirement for Phosphorylation of YxxM Motifs in BCAP
Function lation, respectively.
(A) Tyrosine phosphorylation of wild-type BCAP and BCAP(Y4F) and Contrary to the role of Syk and Btk in promoting BCAP
their association with p85. DT40 cells were stimulated with M4 (4 tyrosine phosphorylation, Lyn appears to play an overall
mg/ml) and subjected to immunoprecipitation with anti-chicken inhibitory role (Figure 3C). One potential explanation for
BCAP Ab. Immunoprecipitates were analyzed by Western blotting this is the ability of Lyn to recruit SH2 domain–containingwith 4G10 (top panel), anti-chicken BCAP Ab (middle panel), and
tyrosine phosphatases into the BCR signaling complexanti-p85 antibody (bottom panel). The positions of BCAP3, BCAP4,
by phosphorylating ITIMs of inhibitory receptors suchBCAP5, and BCAP6 are indicated.
(B and C) Akt (B) and JNK (C) activation. After stimulation with M4 as CD22 and PIR-B (Tamir et al., 2000). In the case of
(4 mg/ml), DT40 cells were subjected to in vitro kinase assay of Akt CD22, it is rapidly tyrosine phosphorylated by Lyn after
and JNK. BCR cross-linking, thereby recruiting SHP-1 (Cornall et
al., 1998; Nishizumi et al., 1998; Smith et al., 1998). As-
suming the existence of such inhibitory receptors inglycolipid-enriched microdomains (GEMs) (Xavier et al.,
1998), whereby the PI3Ks access their substrates such DT40 B cells, the hyperphosphorylation of BCAP in Lyn-
deficient cells could be accounted for by the functionalas PI(4,5)P2 (phosphatidylinositol[4,5]biphosphate) (Pike
and Miller, 1998). Based on these previous observations, loss of inhibitory receptors. This inhibitory function may
not be necessarily conferred by inhibitory receptors. In-we hypothesized that BCAP might be involved in BCR-
induced recruitment of PI3Ks to GEMs. To test this idea, deed, cytoplasmic signaling molecules such as Gab1/2
are also known to recruit SHP-2 in an SH2 phosphoty-we examined the BCR-mediated redistribution of PI3K
p85 in wild-type versus BCAP-deficient cells by fraction- rosine–dependent manner, thereby activating these
phosphatases (Tamir et al., 2000).ation of DT40 cell lysates in sucrose density gradients.
Consistent with the previous reports (Cheng et al., 1999; The deduced amino acid sequence of BCAP contains
one ankyrin repeat-like region, one coiled-coil domain,Aman and Ravichandran, 2000), Lyn was enriched in
Triton-insoluble GEMs (mainly fraction number 4), and and three proline-rich regions (Figure 1C). In Drosophila,
Dof has been identified as a downstream regulator thata-tubulin was excluded from the GEMs (Figure 7). In
unstimulated wild-type DT40 B cells, a small amount of appears to be specific for the fibroblast growth factor
receptor (FGFR)-mediated signal transduction pathwayp85 was located in GEMs, which was increased follow-
ing BCR cross-linking. In contrast, this recruitment was (Vincent et al., 1998). Although the overall homology
between BCAP and Dof is weak, these proteins exhibitmarkedly attenuated in BCAP-deficient cells, although
low level of p85 recruitment still occurred (Figure 7). 54% and 44% homology in the ankyrin repeat-like region
and the coiled-coil domain, which might be importantThese results implicate that BCAP participates in the
recruitment of PI3K to GEMs. for the subcellular localization of Dof and BCAP through
their interactions with other proteins. While Dof has beenThe above observations suggest the possibility that
Immunity
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Figure 7. BCAP Is Involved in BCR-Induced
PI3K Recruitment to Glycolipid-Enriched Mi-
crodomains
Wild-type and BCAP-deficient DT40 cells, un-
stimulated (minus symbol) or stimulated with
4 mg/ml M4 (plus symbol), were lysed and
fractionated in sucrose gradient. Fractions
(30 ml/lane; numbered from low to high den-
sity) were resolved by SDS-PAGE and immu-
noblotted with anti-p85 Ab, anti-chicken
BCAP Ab, anti-Lyn Ab, and anti-tubulin Ab.
shown to be involved in the Ras-ERK pathway (Vincent cells. This recruitment is perturbed by loss of BCAP
(Figure 7). Given the failure of BCAP(Y4F) to restore theet al., 1998), BCR-mediated ERK activation occurs nor-
mally in BCAP-deficient DT40 cells (data not shown). recruitment of the p85 to GEMs (data not shown), the
phosphorylation-dependent interaction between BCAPThis difference might reflect the existence of a greater
number of favored binding sites (YxNx) for the Grb2 SH2 and PI3K p85 would target PI3K to GEMs. Consequently,
the PI3K is allowed to access its substrate PI(4,5)P2, asdomains within Dof (five sites in Dof versus only one
site in BCAP). PI(4,5)P2 is known to be enriched in GEMs (Pike and
Miller, 1998). In addition, binding of PI3K with BCAPChicken BCAP contains 31 potential tyrosines that
may become phosphorylated, and four of these are per se could upregulate the PI3K enzymatic activity,
presumably by its conformation change as previouslywithin consensus binding motifs for the SH2 domain of
PI3K p85. The importance of phosphorylation on these reported for other p85 binding proteins (Shoelson et al.,
1993; Buhl et al., 1997). Both events are likely importantfour tyrosines is directly demonstrated by the failure of
BCAP(Y4F) to restore Akt activation as well as to induci- for PI(3,4,5)P3 generation via BCAP after BCR cross-
linking.bly bind to p85 (Figure 6). Our finding that BCAP(Y4F)
still undergoes tyrosine phosphorylation clearly indi- The reduced JNK activation in BCAP-deficient DT40
B cells following BCR engagement could be accountedcates the existence of additional phosphorylation sites
on BCAP after BCR cross-linking. Although the signifi- for by the decreased PI3K activation. Rac and Cdc42
are thought to be activated by a PH domain–containingcance of these sites has not been addressed by our
study, given that several tyrosine phosphorylated pro- guanine-nucleotide exchange factor, Vav, leading to the
JNK activation (Crespo et al., 1997). Thus, given theteins still coimmunoprecipitate with BCAP(Y4F) (Figure
6A; data not shown), it is possible that other SH2 do- importance of PI(3,4,5)P3 in PH domain–mediated Vav
activation (Han et al., 1998), sufficient amounts ofmain–containing proteins associate with these sites,
thereby contributing, at least in part, to the functions of PI(3,4,5)P3 would be required for Vav activation in its
coupling to the JNK pathway. Because Akt is known toBCAP.
GEMs, sometimes referred to as detergent-insoluble play an antiapoptotic role through phosphorylation of
BAD, caspase 9, IkB kinase (IKK), and Forkhead tran-lipid rafts, have been proposed to function as platforms
for the formation of multicomponent signaling com- scriptional factors (Datta et al., 1999), the enhanced
BCR-mediated apoptosis in BCAP-deficient cells canplexes (Langlet et al., 2000). BCAP is not enriched in
GEMs within the plasma membrane like LAT or Src fam- be explained in part by the decreased activation of Akt.
In addition, given the recent evidence that JNK is alsoily PTKs. Nevertheless, a small fraction of BCAP is local-
ized in GEMs before BCR stimulation, suggesting the involved in an antiapoptotic process (Leppa and Boh-
mann, 1999), the hyperapoptosis observed in BCAP-heterogeneity of subcellular localization of BCAP. Thus,
it would be possible that a small fraction of BCAP under- deficient DT40 cells could be caused by the decreased
activation of both Akt and JNK.goes posttranslational modifications and/or association
with other membrane proteins, thereby being localized The residual PI(3,4,5)P3 generation and the subse-
quent Akt activation in BCAP-deficient DT40 B cellsin GEMs. Additional studies are underway to define the
significance of the small GEM-associated BCAP in ex- clearly demonstrate the involvement of additional mole-
cules for the complete activation of PI3K in B cells.erting its functions.
Similar to the redistribution of PI3K p85 to GEMs ob- An obvious possibility is that, like participation of both
insulin receptor substrate (IRS)-1 and IRS-2 in insulin’sserved after TCR stimulation (Xavier et al., 1998), p85 is
recruited to GEMs after BCR cross-linking in DT40 B metabolic actions (Withers et al., 1999), other BCAP
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then eluted with TBS containing 0.1% CHAPS, 50 mM phenylphos-isoform(s) may exist and function as redundant mole-
phate, 0.1 mM sodium vanadate, and protease inhibitors. After beingcules. Other candidate molecules are Gab, Cbl, and
concentrated and desalted by Centricon-10 (Amicon), final samplesCD19, as these molecules contain YxxM motifs. Indeed,
were subjected to 7% SDS-PAGE gel, transferred to PVDF mem-
these molecules are shown to be tyrosine phosphory- brane (Applied Biosystems), and stained with Ponceau S. The band
lated upon BCR stimulation, thereby associating with for pp100 was excised and digested with Achromobacter protease I.
Digested peptides were chromatographed by reverse-phase HPLCPI3K p85 (reviewed in Gold, 2000). Among these mole-
(Wako Pure Chemical), and amino acid sequencing was performedcules, Cbl is unlikely to play an important role, particu-
with a gas-phase sequencer (Shimadzu, model PPSQ-23). We ob-larly in DT40 B cells, because Cbl-deficient DT40 cells
tained six peptide sequences, as shown in Figure 1 legends.exhibit apparently normal BCR-mediated PI3K activa-
tion (Yasuda et al., 2000). Thus, assuming the expression
cDNA Cloning and Sequencing
of chicken homologs of Gab and CD19 in DT40 B cells, The degenerate oligonucleotides were synthesized based upon
the remaining PI(3,4,5)P3 production and Akt activation the peptide sequences TPGQRQLITLQEQV and IVPYSIEALDK.
32P-labeled oligonucleotides at the 59 end were used as a probein BCAP-deficient cells could be attributable to CD19-
for screening of the plasmid DT40 cDNA library (pJG4-5 vector;and/or Gab-dependent activation of PI3K. In fact, in
GenBank accession number U89961). Eight clones were isolatedmurine splenic B cells, PI3K is recruited to both BCAP
and sequenced. The sequence of the longest insert (clone 2) hasand CD19 after BCR cross-linking (Figures 3A and 3B).
been deposited into GenBank (accession number AF293805). By
The decrease of PI(3,4,5)P3 generation in BCAP-defi- using the obtained BCAP cDNA (clone 2) as a probe, further screen-
cient cells might not merely reflect the quantitative ing of the DT40 cDNA library was performed, leading to the isolation
of clone 11 with the alternative 59 sequence (accession numberchange of PI3K activation during BCR signaling; rather,
AF315784). A mouse EST clone (accession number AA178577) wasqualitative changes of PI3K activation processes might
found by homology search of the NCBI database with the chickenoccur in the mutant cells. For instance, if two steps,
BCAP cDNA sequence. A lZAP mouse cDNA library was screenednamely initiating and sustaining processes, are coordi-
by using the EST DNA as a probe, giving rise to the isolation of
nately required for full activation of the PI3K pathway, 17 clones. The longest insert contained the open reading frame
the initiation process could occur via the above dis- encoding 811 amino acids (accession number AF293806).
cussed molecules such as CD19, and BCAP may be
responsible for maintaining or amplifying PI3K activa- Generation of BCAP-Deficient DT40 Cells
DT40 genomic DNA containing exons that correspond to chickention. In this regard, temporal resolution of our PI(3,4,5)P3
BCAP amino acid residues 223–800 was cloned by the PCR method.and Akt assay systems may not have sufficed enough
The targeting vectors pBCAP-bsr and pBCAP-puro were con-to distinguish these differences. Future studies will be
structed by replacing the 11 kb genomic DNA fragment containing
needed to determine functional interaction(s) between exons that correspond to amino acids 338–721 with bsr and puro
BCAP-dependent and -independent mechanisms in cassettes (Sugawara et al., 1997). These cassettes were flanked by
3.5 kb and 3.5 kb of BCAP genomic sequences on the 59 and 39PI3K activation in B cells.
sides. DT40 cells transfected sequentially with pBCAP-bsr, and
pBCAP-puro were screened as described previously (Sugawara etExperimental Procedures
al., 1997). DT40 cells deficient in Lyn, Syk, or Btk were described
previously (Takata et al., 1994; Takata and Kurosaki, 1996). In theCells and Antibodies
BCAP(Y4F) mutant construct, the codons of tyrosine residues (199,Wild-type and its derivative mutant DT40 cells were cultured in
423, 448, and 463) in chicken BCAP cDNA (clone 2) were changedRPMI1640 supplemented with 10% fetal calf serum (FCS), 1%
to those of phenylalanine by the PCR method. Wild-type and thechicken serum, 50 mM 2-mercaptoethanol, 2 mM L-glutamine, peni-
mutant chicken BCAP cDNAs with the C-terminal flanking FLAGcillin, and streptomycin. COS-7 cells were cultured in Dulbecco’s
epitopic tag were cloned into pcDNA3.1 vector (Invitrogen). BCAP-modified Eagle’s medium containing 10% FCS, 2 mM L-glutamine,
deficient DT40 cells were transfected with FLAG-tagged cDNA con-penicillin, and streptomycin. Preparation of mouse splenic B cells
structs and selected in the presence of 2 mg/ml G-418. Transfectionwas as described previously (Hashimoto et al., 2000). Anti-BCAP
was performed by electroporation at 550V, 25 mF. Expression ofAbs and anti-CD19 Ab were obtained by immunizing rabbits with
transfected cDNA was confirmed by Western blot analysis usingbacterially expressed GST fusion protein containing chicken BCAP
anti-FLAG Ab.(410–540 amino acid region), mouse BCAP (603–797), or mouse
CD19 (C-terminal 49 amino acids). The anti-chicken IgM Ab, M4,
the anti-mouse IgM Ab, anti-phosphotyrosine Ab (4G10), and anti- Immunofluorescence Microscopy
COS-7 cells were transfected with the FLAG-tagged chicken BCAPchicken Lyn Ab were described previously (Ishiai et al., 1999; Hashi-
moto et al., 2000). The following Abs were purchased: anti-p85 Ab cDNA construct by the calcium phosphate method. After 48 hr,
transfected COS cells were grown on coverslips for 6 hr. COS cellsfrom Upstate Biotechnology, anti-Akt1 Ab and anti-a-tubulin Ab
from Santa Cruz Biotechnology, and anti-JNK1 Ab from PharMingen. on coverslips or DT40 cells in suspension were fixed with 3.7%
paraformaldehyde in PBS and permeabilized with 0.1% Triton X-100
in PBS. After treatment with 100 mg/ml RNase for 10 min andPurification of Chicken pp100 and Peptide Sequencing
blocking with 10% FBS-containing PBS (FBS/PBS), cells were incu-DT40 cells (1.5 3 1010) were stimulated for 3 min at 2 3 108 cells/
bated with anti-chicken BCAP Ab for 1 hr and washed with FBS/ml in RPMI1640 with M4 (4 mg/ml) at 378C. Cells were lysed in NP-
PBS three times. Then cells were incubated with 2 mg/ml FITC-40 buffer (1% NP-40, 150 mM NaCl, 20 mM Tris [pH 7.5], and 1 mM
conjugated anti-rabbit IgG Ab (Southern Biotechnology Associates)EDTA) containing 50 mM NaF and 0.5 mM pervanadate supple-
and 0.4 mg/ml propidium iodide for 1 hr and washed with FBS/mented with protease inhibitor as described previously (Takata et
PBS three times. Stained cells were mounted with Fluoromount-Gal., 1994). After centrifugation at 13,000 3 g, supernatant was pre-
(Southern Biotechnology Associates) and analyzed by FLUOVIEWcleaned with Sepharose 4B and then incubated with a p85-SH2(N)
confocal microscope (Olympus).affinity column, which was prepared by coupling 5 mg GST-p85-
SH2(N) protein to 4 ml Glutathione-Sepharose with dimethyl pimeli-
midate. Beads were then washed with ten bed volumes of NP-40 Flow Cytometric Analysis
BCR expression and apoptosis were analyzed by using FACScanlysis buffer and eluted with 50 mM Tris-HCl and 1% SDS for 5 min
at 958C. Eluate was diluted with NP-40 lysis buffer and incubated (Becton Dickinson) as described previously (Yasuda et al., 2000).
The x and y axes for the histograms indicate fluorescence intensitywith 2 ml of protein A Sepharose–conjugated 4G10 for 12 hr at 48C.
Beads were washed with 50 bed volumes of NP-40 lysis buffer and (4-decade-log scales) and relative cell number, respectively.
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Northern Blot Analysis Frontier Science Program. T. O. is a Research Fellow of the Japan
Society for the Promotion of Science.Mouse tissue RNA was prepared from various tissues of 8-week-
old C57/BL6 mice using RNAzol B (Tel-Test Inc.). Multiple mouse
cell line Northern blots were provided by Drs. Goitsuka and Kitamura Received August 9, 2000; revised November 28, 2000.
(Science University of Tokyo). Twenty micrograms of total RNA was
separated in 1% agarose formaldehyde gel, transferred to Hybond- References
N1 membrane (Amersham Pharmacia Biotech), and probed with
32P-labeled mouse BCAP or b-actin cDNA. Aman, M.J., and Ravichandran, K.S. (2000). A requirement for lipid
rafts in B cell receptor induced Ca21 flux. Curr. Biol. 10, 393–396.
Beitz, L.O., Fruman, D.A., Kurosaki, T., Cantley, L.C., and Scharen-Immunoprecipitation and Western Blot Analysis
For immunoprecipitation, cells were solubilized in NP-40 lysis buffer berg, A.M. (1999). Syk is upstream of phosphoinositide 3-kinase in
B cell receptor signaling. J. Biol. Chem. 274, 32662–32666.supplemented with protease and phosphatase inhibitors as de-
scribed previously (Takata et al., 1994), and precleared lysates were Buhl, A.M., and Cambier, J.C. (1999). Phosphorylation of CD19 Y484
sequentially incubated with proper Abs and protein A-agarose. Ly- and Y515, and linked activation of phosphatidylinositol 3-kinase, are
sates or immunoprecipitates were separated by SDS-PAGE gels, required for B cell antigen receptor-mediated activation of Bruton’s
transferred to polyvinyllidene difluoride (PVDF) membrane, and de- tyrosine kinase. J. Immunol. 162, 4438–4446.
tected by the indicated Abs and enhanced chemiluminescence
Buhl, A.M., Pleiman, C.M., Rickert, R.C., and Cambier, J.C. (1997).
(ECL) system (Amersham Pharmacia Biotech).
Qualitative regulation of B cell antigen receptor signaling by CD19:
For in vitro kinase assays of Akt, immunoprecipitates with anti-
selective requirement for PI3-kinase activation, inositol-1,4,5- tris-
Akt1 Ab were washed four times with 0.5 ml of the lysis buffer and
phosphate production and Ca21 mobilization. J. Exp. Med. 186,
twice with 0.1 ml of the assay buffer (20 mM HEPES [pH7.4], 10 mM
1897–1910.
MgCl2, 10 mM MnCl2, 10 mM sodium vanadate, 2 mM dithiothreitol,
Cheng, P.C., Dykstra, M.L., Mitchell, R.N., and Pierce, S.K. (1999).10 mM PKA inhibitor, and 10 mM PKC inhibitor). Half of each immuno-
A role for lipid rafts in B cell antigen receptor signaling and antigenprecipitate was subjected to the kinase reaction in 40 ml of the assay
targeting. J. Exp. Med. 190, 1549–1560.buffer supplemented with 5 mg histone (H2B), 5 mM ATP, and 10
mCi [g-32P]ATP. After 20 min incubation at 308C, the reactions were Cornall, R.J., Cyster, J.G., Hibbs, M.L., Dunn, A.R., Otipoby, K.L.,
terminated by the addition of SDS sample buffer and boiled for 5 Clark, E.A., and Goodnow, C.C. (1998). Polygenic autoimmune traits:
min. The samples were separated by SDS-PAGE gel (15%) and Lyn, CD22, and SHP-1 are limiting elements of a biochemical path-
subjected to autoradiography. The other half of each immunoprecip- way regulating BCR signaling and selection. Immunity 8, 497–508.
itate was used for Western blot analysis to quantify immunoprecipi- Crespo, P., Schuebel, K.E., Ostrom, A.A., Gutkind, J.S., and Bustelo,
tated Akt. In vitro kinase assays of JNK were performed as described X.R. (1997). Phosphotyrosine-dependent activation of Rac-1 GDP/
previously (Hashimoto et al., 1998). GTP exchange by the Vav proto-oncogene product. Nature 385,
169–172.
Datta, S.R., Brunet, A., and Greenberg, M.E. (1999). Cellular survival:Subcellular Fractionation and Preparation of GEM Fractions
a play in three Akts. Genes Dev. 13, 2905–2927.Preparation of cytosolic and membrane fractions of DT40 cells was
performed as described previously (Ishiai et al., 1999). Fractionation DeFranco, A.L. (1997). The complexity of signaling pathways acti-
of DT40 cell lysates in sucrose density gradients for preparation of vated by the BCR. Curr. Opin. Immunol. 9, 296–308.
GEM fractions was described previously (Ishiai et al., 2000).
Engel, P., Zhou, L.J., Ord, D.C., Sato, S., Koller, B., and Tedder,
T.F. (1995). Abnormal B lymphocyte development, activation, and
differentiation in mice that lack or overexpress the CD19 signalPI(3,4,5)P3 and IP3 Analysis
transduction molecule. Immunity 3, 39–50.DT40 cells (107 cells/ml) were radiolabeled in calcium buffer (10 mM
HEPES [pH 7.4], 135 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, Fruman, D.A., Meyers, R.E., and Cantley, L.C. (1998). Phosphoinosi-
and 5.6 mM glucose) with 1 mCi/ml [32P]orthophosphate (NEN Life tide kinases. Annu. Rev. Biochem. 67, 481–507.
Science Products) for 1 hr. After being washed once with calcium Fruman, D.A., Snapper, S.B., Yballe, C.M., Davidson, L., Yu, J.Y.,
buffer, cells (107 cells/time point) were stimulated with M4 (4 mg/ Alt, F.W., and Cantley, L.C. (1999). Impaired B cell development and
ml). The reactions were quenched by addition of 750 ml methanol/ proliferation in absence of phosphoinositide 3-kinase p85a. Science
1.2 N HCl (1:1), and lipid was extracted with 600 ml chloroform. 283, 393–397.
32P-labeled PI(3,4,5)P3 marker was prepared by reacting PI(4,5)P2
Gillham, H., Golding, M.C., Pepperkok, R., and Gullick, W.J. (1999).(Sigma) and [g-32P]ATP in the presence of immunoprecipitates with
Intracellular movement of green fluorescent protein-tagged phos-anti-p85 Ab. For thin-layer chromatography (TLC), samples were
phatidylinositol 3-kinase in response to growth factor receptor sig-spotted onto a silica gel plate (EM Science) pretreated with potas-
naling. J. Cell. Biol. 146, 869–880.sium oxalate and developed in chloroform/acetone/methanol/acetic
Gold, M.R. (2000). Intermediary signaling effectors coupling theacid/water (40:15:13:12:7). The radioactivity of PI(3,4,5)P3 spots was
B-cell receptor to the nucleus. In Current Topics in Microbiologyquantified by using a Fuji FLA2000 bioimaging analyzer and was
and Immunology, Volume 245, L.B. Justement and K.A. Siminovitch,normalized to the total radioactivity in phospholipids of the samples.
ed. (Berlin Heidelberg: Springer-verlag), pp. 78–134.Then the resulting values were normalized to the value at time zero
of BCR stimulation for each of three independent experiments and Han, J., Luby-Phelps, K., Das, B., Shu, X., Xia, Y., Mosteller, R.D.,
averaged. Measurement of IP3 was performed as described pre- Krishna, U.M., Falck, J.R., White, M.A., and Broek, D. (1998). Role
viously (Ishiai et al., 1999). of substrates and products of PI 3-kinase in regulating activation
of Rac-related guanosine triphosphatases by Vav. Science 279,
558–560.
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